Furthermore, liraglutide suppressed hepatic steatosis via the restoration of autophagy, in particular the GLP-1R- transcription factor EB (TFEB)-mediated autophagy-lysosomal pathway [34]. This evidence concerns the gene TFEB and fatty liver disease.